161 related articles for article (PubMed ID: 17690840)
1. Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.
Takei H; Yogeswaren ST; Wong KK; Mehta V; Chintagumpala M; Dauser RC; Lau CC; Adesina AM
J Neurooncol; 2008 Jan; 86(2):183-90. PubMed ID: 17690840
[TBL] [Abstract][Full Text] [Related]
2. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
3. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
4. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
5. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
6. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
7. Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate.
Cui QL; D'Abate L; Fang J; Leong SY; Ludwin S; Kennedy TE; Antel J; Almazan G
Stem Cells Dev; 2012 Jul; 21(11):1831-7. PubMed ID: 22122665
[TBL] [Abstract][Full Text] [Related]
8. Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.
Bannykh SI; Stolt CC; Kim J; Perry A; Wegner M
J Neurooncol; 2006 Jan; 76(2):115-27. PubMed ID: 16205963
[TBL] [Abstract][Full Text] [Related]
9. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
[TBL] [Abstract][Full Text] [Related]
10. Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.
Barrows BD; Rutkowski MJ; Gültekın SH; Parsa AT; Tıhan T
Turk Patoloji Derg; 2012; 28(2):95-103. PubMed ID: 22627626
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.
Lu QR; Park JK; Noll E; Chan JA; Alberta J; Yuk D; Alzamora MG; Louis DN; Stiles CD; Rowitch DH; Black PM
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10851-6. PubMed ID: 11526205
[TBL] [Abstract][Full Text] [Related]
12. Predominant expression of OLIG2 over ID2 in oligodendroglial tumors.
Mikami S; Hirose Y; Yoshida K; Kawase T; Ohnishi A; Nagashima K; Mukai M; Okada Y; Ikeda E
Virchows Arch; 2007 May; 450(5):575-84. PubMed ID: 17431671
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells using triiodothyronine as a inducer with expression of platelet-derived growth factor α as a maturity marker.
Abbaszadeh HA; Tiraihi T; Delshad AR; Saghedi Zadeh M; Taheri T
Iran Biomed J; 2013 Apr; 17(2):62-70. PubMed ID: 23567847
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.
Aguirre-Cruz L; Mokhtari K; Hoang-Xuan K; Marie Y; Criniere E; Taillibert S; Lopes M; Delattre JY; Sanson M
J Neurooncol; 2004 May; 67(3):265-71. PubMed ID: 15164981
[TBL] [Abstract][Full Text] [Related]
15. Activation of FXR pathway does not alter glial cell function.
Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
[TBL] [Abstract][Full Text] [Related]
16. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas.
Horbinski C; Hamilton RL; Lovell C; Burnham J; Pollack IF
Brain Pathol; 2010 May; 20(3):581-8. PubMed ID: 19832838
[TBL] [Abstract][Full Text] [Related]
17. Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.
Margraf LR; Gargan L; Butt Y; Raghunathan N; Bowers DC
Neuro Oncol; 2011 Jul; 13(7):767-74. PubMed ID: 21653594
[TBL] [Abstract][Full Text] [Related]
18. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
19. Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Nakajima M; Shimizu R; Furuta K; Sugino M; Watanabe T; Aoki R; Okuyama S; Furukawa Y
Brain Res; 2016 May; 1639():28-37. PubMed ID: 26944297
[TBL] [Abstract][Full Text] [Related]
20. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
